AbbVie Inc. (ABBV) 是一家上市公司 屬於 醫療保健 板塊，經營於 制药 - 綜合 產業. 公司總部位於 North Chicago, IL, 美国. 現任CEO為 Scott T. Reents.
ABBV 擁有 IPO日期為 2013-01-02, 55,000 名全職員工, 在 NYSE, 市值為 $372.01B.
AbbVie Inc. is a global pharmaceutical company that discovers, develops, manufactures, and markets a diverse portfolio of medicines across multiple therapeutic areas. The company's key products include HUMIRA for autoimmune diseases, SKYRIZI for psoriasis, RINVOQ for rheumatoid arthritis, IMBRUVICA and VENCLEXTA for blood cancers, and MAVYRET for hepatitis C, along with established brands such as Synthroid for hypothyroidism, Botox, Lupron, and Linzess for gastrointestinal conditions. AbbVie also offers specialized treatments in ophthalmology, neurology, and women's health, including eye care solutions and migraine therapies. Headquartered in North Chicago, Illinois, and incorporated in 2012, the company maintains research collaborations to advance its drug pipeline and expand its global reach.
